|
|
|
Breakthrough Medicines for Patients in Need
|
|
Commitment to Access, GlaxoSmithKline’s patient assistance program for oncology
and specialty pharmacy medicines, provides GSK prescription medicines to eligible low
income patients with no third party prescription drug benefits except Medicare Part D
and generic-only coverage. GlaxoSmithKline patient assistance programs provided medicines
valued at over $438 million (Wholesale Acquisition Cost) to almost 415,000 patients during 2008.
Patients with Medicare Part D coverage who qualify for Commitment to Access must submit
proof that they have spent at least $600 on prescription medications through the Medicare
Part D Prescription Drug Plan each calendar year.
|
|
|
